Shannon M. Delaney

2.9k total citations · 1 hit paper
37 papers, 1.8k citations indexed

About

Shannon M. Delaney is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Shannon M. Delaney has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Genetics. Recurrent topics in Shannon M. Delaney's work include Glioma Diagnosis and Treatment (8 papers), DNA Repair Mechanisms (6 papers) and Epigenetics and DNA Methylation (5 papers). Shannon M. Delaney is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), DNA Repair Mechanisms (6 papers) and Epigenetics and DNA Methylation (5 papers). Shannon M. Delaney collaborates with scholars based in United States, China and United Kingdom. Shannon M. Delaney's co-authors include Dmitri V. Mavrodi, Robert F. Bonsall, Linda S. Thomashow, Greg R. Phillips, M. Eileen Dolan, Claudia Wing, Heather E. Wheeler, Masaaki Komatsu, M. Eileen Dolan and R. Stephanie Huang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Shannon M. Delaney

37 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functional Analysis of Genes for Biosynthesis of Pyocyanin and Phenazine-1-Carboxamide from Pseudomonas aeruginosa PAO1

2001 620 citations Dmitri V. Mavrodi, Robert F. Bonsall et al. Journal of Bacteriology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shannon M. Delaney United States	20	1.1k	321	294	230	225	37	1.8k
Jean de Gunzburg France	36	2.2k 2.1×	203 0.6×	384 1.3×	79 0.3×	231 1.0×	93	3.6k
Radovan Komel Slovenia	30	1.8k 1.7×	450 1.4×	305 1.0×	163 0.7×	250 1.1×	149	3.1k
Takahisa Ohta Japan	34	1.9k 1.7×	468 1.5×	598 2.0×	55 0.2×	222 1.0×	179	3.4k
Sylwia Kędracka–Krok Poland	24	967 0.9×	131 0.4×	188 0.6×	94 0.4×	88 0.4×	71	1.6k
Abraham Rimon Israel	24	1.6k 1.4×	445 1.4×	208 0.7×	70 0.3×	401 1.8×	52	2.4k
Haiyan Zhang China	26	1.5k 1.3×	172 0.5×	213 0.7×	82 0.4×	144 0.6×	145	2.5k
Stephen J. Assinder Australia	20	844 0.8×	118 0.4×	196 0.7×	30 0.1×	103 0.5×	45	1.6k
M. Elena Martı́n Spain	31	1.7k 1.6×	157 0.5×	217 0.7×	50 0.2×	318 1.4×	109	2.9k
Hervé Kovacic France	26	762 0.7×	110 0.3×	227 0.8×	55 0.2×	101 0.4×	66	1.8k
Jingyi Zhou China	23	1.0k 0.9×	127 0.4×	439 1.5×	53 0.2×	91 0.4×	104	2.3k

Countries citing papers authored by Shannon M. Delaney

Since Specialization

Citations

This map shows the geographic impact of Shannon M. Delaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon M. Delaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon M. Delaney more than expected).

Fields of papers citing papers by Shannon M. Delaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon M. Delaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon M. Delaney. The network helps show where Shannon M. Delaney may publish in the future.

Co-authorship network of co-authors of Shannon M. Delaney

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon M. Delaney. A scholar is included among the top collaborators of Shannon M. Delaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon M. Delaney. Shannon M. Delaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gamazon, Eric R., Matthew R. Trendowski, Yujia Wen, et al.. (2018). Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma. Scientific Reports. 8(1). 733–733. 12 indexed citations

Delaney, Shannon M., Brian A. Fallon, Armin Alaedini, et al.. (2018). Inflammatory biomarkers in psychosis and clinical high risk populations. Schizophrenia Research. 206. 440–443. 36 indexed citations

Delaney, Shannon M. & Mady Hornig. (2018). Environmental Exposures and Neuropsychiatric Disorders: What Role Does the Gut–Immune–Brain Axis Play?. Current Environmental Health Reports. 5(1). 158–169. 7 indexed citations

Wing, Claudia, et al.. (2017). Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy. Stem Cell Research. 22. 79–88. 47 indexed citations

Shuffrey, Lauren C., Stephen J. Guter, Shannon M. Delaney, et al.. (2017). Is there sexual dimorphism of hyperserotonemia in autism spectrum disorder?. Autism Research. 10(8). 1417–1423. 21 indexed citations

Komatsu, Masaaki, Heather E. Wheeler, Suyoun Chung, et al.. (2015). Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy. Clinical Cancer Research. 21(19). 4337–4346. 36 indexed citations

Morrison, Gladys, Cong Liu, Claudia Wing, et al.. (2015). Evaluation of inter-batch differences in stem-cell derived neurons. Stem Cell Research. 16(1). 140–148. 10 indexed citations

Zhang, Xu, Erika L. Moen, Cong Liu, et al.. (2014). Linking the genetic architecture of cytosine modifications with human complex traits. Human Molecular Genetics. 23(22). 5893–5905. 28 indexed citations

Moen, Erika L., Xu Zhang, Wenbo Mu, et al.. (2013). Genome-Wide Variation of Cytosine Modifications Between European and African Populations and the Implications for Complex Traits. Genetics. 194(4). 987–996. 89 indexed citations

10.

Moen, Erika L., Wenbo Mu, Shannon M. Delaney, et al.. (2012). Abstract 5010: Differences in DNA methylation between the African and European HapMap populations. Cancer Research. 72(8_Supplement). 5010–5010. 3 indexed citations

11.

Zhang, Chunyu, Abdel Elkahloun, Hongling Liao, et al.. (2011). Expression Signatures of the Lipid-Based Akt Inhibitors Phosphatidylinositol Ether Lipid Analogues in NSCLC Cells. Molecular Cancer Therapeutics. 10(7). 1137–1148. 10 indexed citations

12.

Ziliak, Dana, Peter H. O’Donnell, Hae Kyung Im, et al.. (2011). Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers. Translational research. 157(5). 265–272. 36 indexed citations

13.

Mackay, C. Logan, et al.. (2010). Are blood ketones a better predictor than urine ketones of acid base balance in diabetic ketoacidosis?. Practical Diabetes International. 27(9). 396–399. 9 indexed citations

14.

Huang, R. Stephanie, Shiwei Duan, Emily O. Kistner, et al.. (2008). Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity. Cancer Research. 68(9). 3161–3168. 54 indexed citations

15.

Odenike, Olatoyosi, Richard A. Larson, Devika Gajria, et al.. (2008). Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia. Investigational New Drugs. 26(3). 233–239. 44 indexed citations

16.

Nagasubramanian, Ramamoorthy, R. J. Hansen, Shannon M. Delaney, et al.. (2008). Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure. Mutagenesis. 23(5). 341–346. 3 indexed citations

17.

Hansen, R. J., et al.. (2006). Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice. Carcinogenesis. 28(5). 1111–1116. 36 indexed citations

18.

Hansen, Ryan J., Ramamoorthy Nagasubramanian, Shannon M. Delaney, et al.. (2005). Role of O6-Alkylguanine-DNA Alkyltransferase in Protecting against 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-Induced Long-Term Toxicities. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1247–1255. 10 indexed citations

19.

Yeager, Nicholas D., M. Eileen Dolan, Julie M. Gastier, et al.. (2003). O6-Methylguanine-DNA Methyltransferase Activity and Promoter Methylation Status in Pediatric Rhabdomyosarcoma. Journal of Pediatric Hematology/Oncology. 25(12). 941–947. 6 indexed citations

20.

Mavrodi, Dmitri V., et al.. (2001). Functional Analysis of Genes for Biosynthesis of Pyocyanin and Phenazine-1-Carboxamide from Pseudomonas aeruginosa PAO1. Journal of Bacteriology. 183(21). 6454–6465. 620 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact